Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: Implications for intermittent therapeutic strategies

Journal of Infectious Diseases

Volumn 186, Issue 6, 2002, Pages 851-854

  Tebas, Pablo ^a   Henry, Keith ^b   Mondy, Kristin ^a   Deeks, Steven ^c   Valdez, Herman ^d   Cohen, Cal ^e   Powderly, William G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HELPER CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; AGING; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LOGISTIC MODELS; MALE; RNA, VIRAL; TIME FACTORS; VIRAL LOAD;

EID: 0037105728     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/342603     Document Type: Article

References (11)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Adverse effects of antiretroviral therapy
3. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy
4. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
5. + lymphocyte count <200 cells/mL) is associated with increased risk of death
6. Long-term survival after initiation of antiretroviral therapy
7. Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters
8. Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses
9. A tale of two futures: HIV and antiretroviral therapy in San Francisco